South Carolina coach Dawn Staley is Philadelphia to her core. She was born in the city, played for its Dobbins Tech High School, played professionally for the Philadelphia Rage in the old American ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

WASHINGTON (AP) — The FBI agents who searched Donald Trump’s Mar-a-Lago estate found boxes of classified documents in his office and storage room and retrieved sensitive government secrets ...

Having spent all of May and half of June in wards full of desperately sick babies, I have been a fierce supporter of vaccines ever since. Recently, the government announced that the relatively new ...

SAN DIEGO (AP) — Ludvig Aberg and Lanto Griffin shared the lead Thursday at Torrey Pines in the Farmers Insurance Open after ferocious wind forced an 86-minute delay and prevented dozens of ...

“The new footprint of the research organization will match the needs of a prioritized preclinical portfolio and a shift of resources to external opportunities,” the spokesperson told Fierce ...

Joining MotoGP in 2015, Jack Miller spent his opening three seasons at Honda, where Marc Marquez was already established as HRC’s superstar rider. The Spaniard had raised his title tally to four ...

Fire crews responded to a brush fire Monday night near Auto Center Drive in Ventura. The blaze was reported around 6:50 p.m. in the Santa Clara River bottom, in an area between Ventura and Oxnard ...

The Palisades fire has spurred criticism of the LAFD’s first female and LGBTQ leader. After Crowley called out City Hall over a lack of funding, union leaders say they back her “110%” With ...

As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere with a $1 billion deal for the Chinese biopharma's phase 1 T-cell engager. Later during ...

Fierce Pharma’s Fraiser Kansteiner and Fierce Biotech’s Gabrielle Masson discuss 2024’s layoff count, the state of GLP-1 supplies, the future of clinical trial research, potential policy ...